Blood test may predict ovarian cancer progression earlier

NCT ID NCT06588322

Recruiting now Knowledge-focused Sponsor: Institut Claudius Regaud Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated Jun 12, 2026 · Updated 30 times

Summary

This study looks at whether a simple blood test can spot changes in the BRCA gene that might signal ovarian cancer is getting worse. Researchers will collect blood samples from 130 patients with BRCA-mutated ovarian cancer who are taking a maintenance drug called Olaparib (sometimes with another drug). The goal is to see if detecting these gene changes early can help doctors identify disease progression sooner than standard methods.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Chu de Limoges
RECRUITING

Limoges, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
Chu de Nimes
RECRUITING

Nîmes, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
INSTITUT DE CANCEROLOGIE DE L'OUEST - Site Angers
RECRUITING

Angers, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
INSTITUT DE CANCEROLOGIE DE L'OUEST - Site Saint-Herblain
RECRUITING

Saint-Herblain, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
IUCT-O
RECRUITING

Toulouse, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
Institut Bergonie
RECRUITING

Bordeaux, France

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

OVARIAN CANCER